S&P 500   4,397.94 (-1.89%)
DOW   34,265.37 (-1.30%)
QQQ   351.69 (-2.77%)
AAPL   162.41 (-1.28%)
MSFT   296.03 (-1.85%)
FB   303.17 (-4.23%)
GOOGL   2,607.03 (-2.22%)
AMZN   2,852.86 (-5.95%)
TSLA   943.90 (-5.26%)
NVDA   233.74 (-3.21%)
BABA   123.23 (-5.95%)
NIO   27.35 (-6.11%)
AMD   118.81 (-2.53%)
CGC   7.29 (-3.57%)
MU   81.93 (-3.69%)
GE   96.30 (-1.98%)
T   26.61 (-1.52%)
F   20.65 (-4.62%)
DIS   137.38 (-6.94%)
AMC   17.97 (-0.55%)
PFE   52.79 (-2.33%)
ACB   4.46 (-6.11%)
BA   205.44 (-4.09%)
S&P 500   4,397.94 (-1.89%)
DOW   34,265.37 (-1.30%)
QQQ   351.69 (-2.77%)
AAPL   162.41 (-1.28%)
MSFT   296.03 (-1.85%)
FB   303.17 (-4.23%)
GOOGL   2,607.03 (-2.22%)
AMZN   2,852.86 (-5.95%)
TSLA   943.90 (-5.26%)
NVDA   233.74 (-3.21%)
BABA   123.23 (-5.95%)
NIO   27.35 (-6.11%)
AMD   118.81 (-2.53%)
CGC   7.29 (-3.57%)
MU   81.93 (-3.69%)
GE   96.30 (-1.98%)
T   26.61 (-1.52%)
F   20.65 (-4.62%)
DIS   137.38 (-6.94%)
AMC   17.97 (-0.55%)
PFE   52.79 (-2.33%)
ACB   4.46 (-6.11%)
BA   205.44 (-4.09%)
S&P 500   4,397.94 (-1.89%)
DOW   34,265.37 (-1.30%)
QQQ   351.69 (-2.77%)
AAPL   162.41 (-1.28%)
MSFT   296.03 (-1.85%)
FB   303.17 (-4.23%)
GOOGL   2,607.03 (-2.22%)
AMZN   2,852.86 (-5.95%)
TSLA   943.90 (-5.26%)
NVDA   233.74 (-3.21%)
BABA   123.23 (-5.95%)
NIO   27.35 (-6.11%)
AMD   118.81 (-2.53%)
CGC   7.29 (-3.57%)
MU   81.93 (-3.69%)
GE   96.30 (-1.98%)
T   26.61 (-1.52%)
F   20.65 (-4.62%)
DIS   137.38 (-6.94%)
AMC   17.97 (-0.55%)
PFE   52.79 (-2.33%)
ACB   4.46 (-6.11%)
BA   205.44 (-4.09%)
S&P 500   4,397.94 (-1.89%)
DOW   34,265.37 (-1.30%)
QQQ   351.69 (-2.77%)
AAPL   162.41 (-1.28%)
MSFT   296.03 (-1.85%)
FB   303.17 (-4.23%)
GOOGL   2,607.03 (-2.22%)
AMZN   2,852.86 (-5.95%)
TSLA   943.90 (-5.26%)
NVDA   233.74 (-3.21%)
BABA   123.23 (-5.95%)
NIO   27.35 (-6.11%)
AMD   118.81 (-2.53%)
CGC   7.29 (-3.57%)
MU   81.93 (-3.69%)
GE   96.30 (-1.98%)
T   26.61 (-1.52%)
F   20.65 (-4.62%)
DIS   137.38 (-6.94%)
AMC   17.97 (-0.55%)
PFE   52.79 (-2.33%)
ACB   4.46 (-6.11%)
BA   205.44 (-4.09%)
NASDAQ:NOVT

Novanta Stock Forecast, Price & News

$144.27
+1.64 (+1.15%)
(As of 01/21/2022 04:00 PM ET)
Add
Compare
Today's Range
$141.35
$147.43
50-Day Range
$142.63
$176.33
52-Week Range
$118.73
$184.44
Volume
159,388 shs
Average Volume
104,399 shs
Market Capitalization
$5.14 billion
P/E Ratio
104.54
Dividend Yield
N/A
Beta
1
30 days | 90 days | 365 days | Advanced Chart
Receive NOVT News and Ratings via Email

Sign-up to receive the latest news and ratings for Novanta and its competitors with MarketBeat's FREE daily newsletter.


Novanta logo

About Novanta

Novanta, Inc. engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products. The Vision segment offers a range of medical grade technologies, including medical insufflators, pumps and related disposables; surgical displays and operating room integration technologies; optical data collection and machine vision technologies; radio frequency identification technologies; thermal printers; spectrometry technologies; and embedded touch screen solutions. The Precision Motion segment includes optical encoders, precision motor and motion control technology, air bearing spindles, and precision machined components to customers. The company was founded in 1968 and is headquartered in Bedford, MA.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Miscellaneous electrical machinery, equipment, & supplies
Sub-Industry
N/A
Current Symbol
NASDAQ:NOVT
Previous Symbol
NASDAQ:GSIG
Employees
2,200
Year Founded
N/A

Sales & Book Value

Annual Sales
$590.62 million
Cash Flow
$2.85 per share
Book Value
$13.56 per share

Profitability

Net Income
$44.52 million
Pretax Margin
7.95%

Debt

Price-To-Earnings

Miscellaneous

Free Float
34,390,000
Market Cap
$5.14 billion
Optionable
Optionable

Company Calendar

Last Earnings
11/09/2021
Today
1/21/2022
Next Earnings (Confirmed)
3/01/2022
Fiscal Year End
12/31/2022

MarketRank

Overall MarketRank

1.86 out of 5 stars

Computer And Technology Sector

543rd out of 895 stocks

Miscellaneous Electrical Machinery, Equipment, & Supplies Industry

15th out of 31 stocks

Analyst Opinion: 0.0Community Rank: 4.9Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 1.9 5 -4 -3 -2 -1 -












Novanta (NASDAQ:NOVT) Frequently Asked Questions

Is Novanta a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Novanta in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" Novanta stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NOVT, but not buy additional shares or sell existing shares.
View analyst ratings for Novanta
or view top-rated stocks.

How has Novanta's stock price been impacted by Coronavirus?

Novanta's stock was trading at $79.04 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, NOVT shares have increased by 82.5% and is now trading at $144.27.
View which stocks have been most impacted by COVID-19
.

When is Novanta's next earnings date?

Novanta is scheduled to release its next quarterly earnings announcement on Tuesday, March 1st 2022.
View our earnings forecast for Novanta
.

How can I listen to Novanta's earnings call?

Novanta will be holding an earnings conference call on Tuesday, March 1st at 10:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Novanta's earnings last quarter?

Novanta Inc. (NASDAQ:NOVT) released its quarterly earnings results on Tuesday, November, 9th. The technology company reported $0.75 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.60 by $0.15. The technology company had revenue of $177.73 million for the quarter, compared to analyst estimates of $172.06 million. Novanta had a trailing twelve-month return on equity of 18.21% and a net margin of 7.51%. Novanta's revenue was up 24.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.42 EPS.
View Novanta's earnings history
.

What guidance has Novanta issued on next quarter's earnings?

Novanta issued an update on its FY 2021 earnings guidance on Tuesday, December, 7th. The company provided earnings per share guidance of $2.550-$2.620 for the period, compared to the Thomson Reuters consensus estimate of $2.450. The company issued revenue guidance of $693 million-$703 million, compared to the consensus revenue estimate of $689.89 million.

Who are Novanta's key executives?

Novanta's management team includes the following people:

What is Matthijs Glastra's approval rating as Novanta's CEO?

44 employees have rated Novanta CEO Matthijs Glastra on Glassdoor.com. Matthijs Glastra has an approval rating of 87% among Novanta's employees.

What other stocks do shareholders of Novanta own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Novanta investors own include NVIDIA (NVDA), Alibaba Group (BABA), Gilead Sciences (GILD), Intuitive Surgical (ISRG), Lam Research (LRCX), Altria Group (MO), AT&T (T), Abiomed (ABMD), Advanced Micro Devices (AMD) and Broadcom (AVGO).

What is Novanta's stock symbol?

Novanta trades on the NASDAQ under the ticker symbol "NOVT."

Who are Novanta's major shareholders?

Novanta's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Conestoga Capital Advisors LLC (3.44%), Spire Wealth Management (0.29%), Exchange Traded Concepts LLC (0.04%), Baillie Gifford & Co. (0.02%) and Koshinski Asset Management Inc. (0.00%). Company insiders that own Novanta stock include Brian S Young, Matthijs Glastra, Peter L Chang and Robert Buckley.
View institutional ownership trends for Novanta
.

Which institutional investors are selling Novanta stock?

NOVT stock was sold by a variety of institutional investors in the last quarter, including Exchange Traded Concepts LLC, and Koshinski Asset Management Inc.. Company insiders that have sold Novanta company stock in the last year include Matthijs Glastra, and Robert Buckley.
View insider buying and selling activity for Novanta
or view top insider-selling stocks.

Which institutional investors are buying Novanta stock?

NOVT stock was purchased by a variety of institutional investors in the last quarter, including Conestoga Capital Advisors LLC, Baillie Gifford & Co., and Spire Wealth Management.
View insider buying and selling activity for Novanta
or or view top insider-buying stocks.

How do I buy shares of Novanta?

Shares of NOVT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Novanta's stock price today?

One share of NOVT stock can currently be purchased for approximately $144.27.

How much money does Novanta make?

Novanta has a market capitalization of $5.14 billion and generates $590.62 million in revenue each year. The technology company earns $44.52 million in net income (profit) each year or $1.38 on an earnings per share basis.

How many employees does Novanta have?

Novanta employs 2,200 workers across the globe.

What is Novanta's official website?

The official website for Novanta is www.novanta.com.

Where are Novanta's headquarters?

Novanta is headquartered at 125 Middlesex Turnpike, Bedford MA, 01730.

How can I contact Novanta?

Novanta's mailing address is 125 Middlesex Turnpike, Bedford MA, 01730. The technology company can be reached via phone at (781) 266-5700, via email at [email protected], or via fax at 781-266-5114.


This page was last updated on 1/21/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.